FALLS CHURCH, Va., Oct. 6, 2016
FALLS CHURCH, Va., Oct. 6, 2016 /PRNewswire/ -- CSRA was recently awarded a $34 million contract to support the scientific peer review of grant applications received by the Cancer Prevention and Research Institute of Texas (CPRIT). The agency's mission is to enhance the potential for medical or scientific breakthroughs in cancer prevention and cures by expediting innovation in research. The single-award, recompete contract has a one-year base period of performance and includes four, one-year options.
CSRA will support CPRIT's endeavor to position the state of Texas as a world-class leader in cancer research and prevention services by providing various scientific management, information technology and administrative services, including:
"We're leveraging our best technology, deep knowledge of peer review best practices, which spans decades, and our close partnership with CPRIT to help the agency fund cancer research and prevention initiatives that will truly make an impact in people's lives," said Paul Nedzbala, CSRA executive vice president, Health and Civil Group.
About CSRA Inc.
Every day CSRA (NYSE: CSRA) makes a difference in how the government serves our country and our citizens. We deliver a broad range of innovative, cloud-enabled, next-generation IT solutions and professional services to help our customers modernize their legacy systems, protect their applications, infrastructure, and assets and improve the effectiveness and efficiency of mission-critical functions for our warfighters and our citizens. Our 18,000 employees understand that success is a matter of perseverance, courage, adaptability and experience. CSRA is headquartered in Falls Church, Virginia. To learn more about CSRA, visit www.csra.com.
All statements in this press release and in all future press releases that do not directly and exclusively relate to historical facts constitute "forward-looking statements" within the meaning of the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements represent CSRA's intentions, plans, expectations and beliefs, including statements about network and asset protection and improving mission-critical functions. The forward-looking statements are subject to risks, uncertainties and other factors, many of which are outside the control of CSRA. These factors could cause actual results to differ materially from forward-looking statements. For a written description of these factors, see the sections titled "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" in CSRA's most recent Annual Report on Form 10-K and any updating information in subsequent SEC filings. CSRA disclaims any intention or obligation to update these forward-looking statements whether as a result of subsequent event or otherwise, except as required by law.
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/csra-improves-quality-of-funding-efforts-for-cancer-research-and-prevention-300340151.html
SOURCE CSRA Inc.PR Newswire
Last updated on: 06/10/2016
PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.